Minor Bupleurum Decoction is a common TCM compound and a classic prescription that can best reflect the"harmonizing method',of TCM.But there are many differences on the usage and dosage of Minor Bupleurum Dec...Minor Bupleurum Decoction is a common TCM compound and a classic prescription that can best reflect the"harmonizing method',of TCM.But there are many differences on the usage and dosage of Minor Bupleurum Decoction.Combined with the clinical treatment experience,this paper summarizes the experience of Minor Bupleurum Decoction in the clinical treatment of diseases.It is hoped that relevant suggestions can be provided for clinicians to improve the clinical therapeutic effect of Minor Bupleurum Decoction.展开更多
The objective of this study is to summarize the pharmacological effects and the mechanisms of action of Xiao Chai Hu Tang(XCHT, Minor Bupleurum Decoction) on liver diseases, so as to give relevant researchers a valuab...The objective of this study is to summarize the pharmacological effects and the mechanisms of action of Xiao Chai Hu Tang(XCHT, Minor Bupleurum Decoction) on liver diseases, so as to give relevant researchers a valuable insight and benefit patients with hepatopathy. PubMed was used to search for and collect scientific publications related to XCHT and liver diseases from 1986 to 2016. The available scientific results or evidence were read, classified, and analyzed. XCHT showed clinical efficacy in patients with hepatic diseases including hepatitis,hepatic fibrosis, and hepatoma. The mechanisms involved the production of cytokines, the regulation of immune function, the suppression of lipid peroxidation, etc., XCHT might work on the metabolism of some medications such as tolbutamide by the regulation of gastric emptying and intragastric pH. XCHT exhibited a very low toxicity profile, such as interstitial pneumonia due to duration of medication,patients' age, and drug combination. XCHT has been a eutherapeutic supplemental remedy for liver diseases. However, many mechanisms of action and effects of XCHT on new types of liver diseases still remain unclear, so more and more animal experiments and human clinical trials are needed to obtain enough proofs for the clinical use of XCHT in new types of hepatosis such as nonalcoholic fatty liver disease and autoimmune liver disease.展开更多
文摘Minor Bupleurum Decoction is a common TCM compound and a classic prescription that can best reflect the"harmonizing method',of TCM.But there are many differences on the usage and dosage of Minor Bupleurum Decoction.Combined with the clinical treatment experience,this paper summarizes the experience of Minor Bupleurum Decoction in the clinical treatment of diseases.It is hoped that relevant suggestions can be provided for clinicians to improve the clinical therapeutic effect of Minor Bupleurum Decoction.
基金supported by grants from the Science and Technology Commission Foundation of Shanghai MunicipalityChina(grants 13401902801)
文摘The objective of this study is to summarize the pharmacological effects and the mechanisms of action of Xiao Chai Hu Tang(XCHT, Minor Bupleurum Decoction) on liver diseases, so as to give relevant researchers a valuable insight and benefit patients with hepatopathy. PubMed was used to search for and collect scientific publications related to XCHT and liver diseases from 1986 to 2016. The available scientific results or evidence were read, classified, and analyzed. XCHT showed clinical efficacy in patients with hepatic diseases including hepatitis,hepatic fibrosis, and hepatoma. The mechanisms involved the production of cytokines, the regulation of immune function, the suppression of lipid peroxidation, etc., XCHT might work on the metabolism of some medications such as tolbutamide by the regulation of gastric emptying and intragastric pH. XCHT exhibited a very low toxicity profile, such as interstitial pneumonia due to duration of medication,patients' age, and drug combination. XCHT has been a eutherapeutic supplemental remedy for liver diseases. However, many mechanisms of action and effects of XCHT on new types of liver diseases still remain unclear, so more and more animal experiments and human clinical trials are needed to obtain enough proofs for the clinical use of XCHT in new types of hepatosis such as nonalcoholic fatty liver disease and autoimmune liver disease.
